
Report ID: SQMIG35I2308
Report ID:
SQMIG35I2308 |
Region:
Global |
Published Date: September, 2024
Pages:
219
|
Tables:
68 |
Figures:
75
The global human growth hormone market presents a hybrid competition between ‘old fashioned' big pharmaceuticals and ‘upstart' newcomers. Braun Medical, Inc., Genentech (a division of Roche), Pfizer, Merck KGaA and Novo Nordisk are amongst the key global players with a strong market share and innovation. These firms concentrate on novel recombinant methods and aggressive marketing to fortify their firms' positions. More factors of competition emerge with increased cooperation and formation of strategic alliances, in turn resulting in more progress made in HGH therapies.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35I2308